Back to Search Start Over

FAN1, a DNA Repair Nuclease, as a Modifier of Repeat Expansion Disorders.

Authors :
Deshmukh AL
Porro A
Mohiuddin M
Lanni S
Panigrahi GB
Caron MC
Masson JY
Sartori AA
Pearson CE
Source :
Journal of Huntington's disease [J Huntingtons Dis] 2021; Vol. 10 (1), pp. 95-122.
Publication Year :
2021

Abstract

FAN1 encodes a DNA repair nuclease. Genetic deficiencies, copy number variants, and single nucleotide variants of FAN1 have been linked to karyomegalic interstitial nephritis, 15q13.3 microdeletion/microduplication syndrome (autism, schizophrenia, and epilepsy), cancer, and most recently repeat expansion diseases. For seven CAG repeat expansion diseases (Huntington's disease (HD) and certain spinocerebellar ataxias), modification of age of onset is linked to variants of specific DNA repair proteins. FAN1 variants are the strongest modifiers. Non-coding disease-delaying FAN1 variants and coding disease-hastening variants (p.R507H and p.R377W) are known, where the former may lead to increased FAN1 levels and the latter have unknown effects upon FAN1 functions. Current thoughts are that ongoing repeat expansions in disease-vulnerable tissues, as individuals age, promote disease onset. Fan1 is required to suppress against high levels of ongoing somatic CAG and CGG repeat expansions in tissues of HD and FMR1 transgenic mice respectively, in addition to participating in DNA interstrand crosslink repair. FAN1 is also a modifier of autism, schizophrenia, and epilepsy. Coupled with the association of these diseases with repeat expansions, this suggests a common mechanism, by which FAN1 modifies repeat diseases. Yet how any of the FAN1 variants modify disease is unknown. Here, we review FAN1 variants, associated clinical effects, protein structure, and the enzyme's attributed functional roles. We highlight how variants may alter its activities in DNA damage response and/or repeat instability. A thorough awareness of the FAN1 gene and FAN1 protein functions will reveal if and how it may be targeted for clinical benefit.

Details

Language :
English
ISSN :
1879-6400
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Journal of Huntington's disease
Publication Type :
Academic Journal
Accession number :
33579867
Full Text :
https://doi.org/10.3233/JHD-200448